BRIEF published on 03/26/2026 at 07:35, 3 months ago Stefan Bauerreis Appointed as New CFO of Medios AG CFO Appointment Medios AG Financial Leadership Specialty Pharma Stefan Bauerreis
PRESS RELEASE published on 03/26/2026 at 07:30, 3 months ago Stefan Bauerreis becomes new Chief Financial Officer (CFO) of Medios AG Stefan Bauerreis appointed new CFO of Medios AG, bringing extensive finance experience. Medios announces key events for 2026 financial year CFO Finance Medios AG Stefan Bauerreis 2026 Financial Year
BRIEF published on 03/06/2026 at 08:22, 3 months 20 days ago Falk Neukirch's Tenure as CFO of Medios AG to Conclude in April 2026 Chief Financial Officer Leadership Transition Medios AG Financial Strategy Falk Neukirch
BRIEF published on 03/06/2026 at 08:22, 3 months 20 days ago Le mandat de Falk Neukirch en tant que directeur financier de Medios AG prendra fin en avril 2026. Stratégie Financière Medios AG Directeur Financier Transition Du Leadership Falk Neukirch
PRESS RELEASE published on 03/06/2026 at 08:17, 3 months 20 days ago Appointment of Falk Neukirch as Chief Financial Officer to expire on April 30, 2026 Medios AG announces the expiration of Falk Neukirch's term as Chief Financial Officer in April 2026. Neukirch led successful financial restructuring and international expansion Chief Financial Officer International Expansion Medios AG Financial Restructuring Falk Neukirch
BRIEF published on 01/19/2026 at 10:05, 5 months 7 days ago Medios AG Enters Medicinal Cannabis Market European Market Medios AG Pharmaceutical Distribution Medicinal Cannabis Bedrocan Partnership
BRIEF published on 01/19/2026 at 10:05, 5 months 7 days ago Medios AG entre sur le marché du cannabis médicinal Marché Européen Medios AG Distribution Pharmaceutique Cannabis Médicinal Partenariat Bedrocan
PRESS RELEASE published on 01/19/2026 at 10:00, 5 months 7 days ago Medios AG enters market for medicinal cannabis Medios AG expands into medicinal cannabis market with exclusive distribution rights for Bedrocan products in Europe, strengthening expertise in oncology and neurology Pharmaceuticals Oncology Medios AG Medicinal Cannabis Bedrocan
BRIEF published on 11/11/2025 at 07:29, 7 months 15 days ago Medios AG annonce une forte croissance de ses bénéfices début 2025 EBITDA Performance Financière Medios AG Croissance Des Revenus Médicaments
BRIEF published on 11/11/2025 at 07:29, 7 months 15 days ago Medios AG Reports Robust Earnings Growth in Early 2025 EBITDA Revenue Growth Financial Performance Pharmaceuticals Medios AG
Published on 06/26/2026 at 01:40, 9 hours 4 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 11 hours 14 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 12 hours 14 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 13 hours 12 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 19 hours 14 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 10:30, 14 minutes ago Uniper and Skyborn Renewables sign offshore wind PPA
Published on 06/26/2026 at 10:25, 19 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 06/26/2026 at 10:25, 19 minutes ago Beijing Art Season 2026 Concludes with Record Public Engagement
Published on 06/26/2026 at 10:15, 29 minutes ago FP Markets expands its share CFD portfolio with landmark SpaceX (SPCX) listing
Published on 06/26/2026 at 10:00, 44 minutes ago Europe and China Must Pivot from Tech Rivalry to 'Constructive Engagement' in AI Era, Warn Leaders at CEIBS Forums
Published on 06/26/2026 at 07:00, 3 hours 44 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 3 hours 44 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 15 hours 59 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 16 hours 14 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 16 hours 54 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
